NEIMETH — NEIMETH INTERNATIONAL PHARMACEUTICALS Disclosures
3 filings on the Nigerian Exchange Group.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) is listed on the Nigerian Exchange Group (NGX). This page tracks every regulatory disclosure NEIMETH INTERNATIONAL PHARMACEUTICALS has filed with the exchange — covering corporate actions, board-meeting notices and director dealings — with plain-English summaries and direct links to each official PDF. The most recent filing was on 27 Oct 2026, and the records here go back to 6 Oct 2026. NEIMETH INTERNATIONAL PHARMACEUTICALS has a market capitalisation of about ₦39.31B and currently carries a HOLD signal on Aboki Forex's fundamental model.
NEIMETH Stock Snapshot
HOLD · 51.5/100Market Cap
₦39.31B
P/E Ratio
39.90
EPS (₦)
0.23
ROE %
35.84
Div Yield %
—
P/B Ratio
14.30
Latest NEIMETH filings
Corporate Action 27 Oct 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC-NOTICE OF OUTCOME OF BOARD MEETING
* The Board of Directors of Neimeth International Pharmaceuticals Plc held a meeting on Tuesday, 27th October 2026.
* The Board approved the Company's Unaudited Financial Statements for Q3 ended 30th September 2026 (2026, Q3 UFS), which will be filed on or before 30th October 2026.
* The previously announced closed period for trading in the company's shares by insiders and connected persons remains in effect until 24 hours after the 2026, Q3 UFS is released to the public.
📄 View PDF
Board Meeting 14 Oct 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- NOTICES OF BOARD MEETING (BM) - NOTICE
* Neimeth International Pharmaceuticals Plc. will hold a Board of Directors meeting on Tuesday, 27th October 2026, to consider and approve its Unaudited Financial Statements for the period ended 30th September 2026 (2026 Q3, UFS).
* The company commenced a closed period starting 1st October 2026, which will run until 24 hours after the 2026 Q3, UFS is released to the public.
* Directors and other insiders have been notified not to trade in the company's securities during this closed period.
📄 View PDF
Director Dealing 6 Oct 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC DIRECTORSDEALINGS
* Clinoscope Services Limited, a substantial shareholder of Neimeth International Pharmaceuticals Plc., notified the company of share dealings.
* The insider purchased a total of 2,810,304 ordinary shares between September 21 and September 28, 2026, at an average price of ₦8.16.
* The transactions were executed in Lagos across four distinct price points ranging from ₦7.30 to ₦8.60 per share.
📄 View PDF
What these NEIMETH disclosures mean
Corporate Action
Events such as dividend declarations, bonus issues, rights issues, share splits or mergers that directly affect NEIMETH shareholders' holdings.
Board Meeting
Notice that NEIMETH INTERNATIONAL PHARMACEUTICALS's board of directors is meeting to consider results, dividends or other corporate matters. Board-meeting notices often precede a financial results release.
Director Dealing
Disclosure of purchases or sales of NEIMETH shares by the company's directors and other insiders, as required by Nigerian Exchange rules.
NEIMETH disclosures — frequently asked questions
NEIMETH INTERNATIONAL PHARMACEUTICALS has 3 recent disclosures on record on the Nigerian Exchange Group, covering corporate actions, board-meeting notices and director dealings. The most recent was filed on 27 Oct 2026. Each filing on this page links to the official PDF on the NGX document library.
Every NEIMETH disclosure on this page links directly to the official PDF published on the Nigerian Exchange (NGX) document library. You can also get push notifications the moment NEIMETH INTERNATIONAL PHARMACEUTICALS files a new disclosure by using the Aboki Forex app.
Based on Aboki Forex's fundamental model, NEIMETH currently carries a HOLD signal with a fundamental score of 51.5/100, a P/E ratio of 39.90 and a return on equity of 35.84%. This is not investment advice — review the full fundamentals and the latest disclosures before deciding.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) has a market capitalisation of approximately ₦39.31B on the Nigerian Exchange Group.
NGX-listed companies like NEIMETH INTERNATIONAL PHARMACEUTICALS file disclosures whenever there is a material event — typically quarterly and annual financial results, plus board meetings, AGM notices, dividend declarations and director dealings as they happen. This page is rebuilt regularly so the latest NEIMETH filings always appear at the top.